Different mechanisms can explain the anti-cancer activity of Ivermectin, including inhibition of MDR, modulation of Akt/mTOR, and Wnt/TCF signaling pathways, inactivation of PAK-1 expression, among others [41,100,101,102,103,104,105]. The gene discussed is PAK1; the disease is cancer.